As Meaningful Use moved to Stage 3 (MU3) in 2015, the Centers for Medicare and Medicaid Services (CMS) added APIs (application programming interface) as an alternative or complement to patient portals. But are these two digital health tools at odds with each other? And where do APIs fit in with Meaningful Use Stage 3? An […]
There are two questions from Eligible Professional specialists about the CMS EHR Incentives that I’m asked over and over again. Question 1: “Do specialists have to meet all of the required Core Set Meaningful Use objectives? We don’t do vitals, we don’t prescribe, we don’t ______ (fill in the blank).” The Meaningful Use tablets that […]
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
By now we all (hopefully) know the ABCs of the CMS EHR Incentive Program: Registration – Meaningful Use of Certified EHR Technology – Attestation. After attestation you hope to get a check so you can go out and buy your second iPad plus a few other toys. Maybe even take a trip to that all-inclusive resort in […]
Finally. We are less than two weeks away from the first Medicare EPs being able to submit online attestation in support of their application for CMS EHR incentives. In early April, the first wave of EPs will have met the requirement for ninety consecutive days of the meaningful use of Complete Certified EHR Technology. Registration […]